Subscribe to the Wall Street Grapevine Newsletter Now and Get Free Alerts On Stock Ready To Explode!

By submitting this form, you are consenting to receive marketing emails from: . You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

APTO stock

Aptose Biosciences Inc. (NASDAQ:APTO) Stock Corrects 15% in a Month: A Good Opportunity?

Aptose Biosciences Inc. (NASDAQ:APTO) dropped 15% in a month after the company announced that it would report its financial results and offer a corporate update for the quarter ending June 30, 2021, on August 3, 2021. Recently, the company released corporate highlights from the EHA 2021 virtual congress. The event focused current Luxeptinib clinical status. …

Continue reading “Aptose Biosciences Inc. (NASDAQ:APTO) Stock Corrects 15% in a Month: A Good Opportunity?”

Subscribe to the Wall Street Grapevine Newsletter Now and Get Free Alerts On Stocks Ready To Explode!

By submitting this form, you are consenting to receive marketing emails from: . You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact
*By submitting your information you agree to the terms of our Privacy Policy. You will receive the DRP Journal newsletter, and third party offers. You can unsubscribe anytime by selecting unsubscribe at the bottom of our emails.